HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Raises Price Target to $85

Benzinga · 06/02/2025 12:53
HC Wainwright & Co. analyst Arthur He maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $75 to $85.